Glenmark to market Azathioprine tablets in the US

BS Reporter / New Delhi November 20, 2008, 11:52 IST

Glenmark Generics, a subsidiary of pharma major Glenmark, has gained the full marketing rights for distributing Azathioprine 50 mg tablets in the US.

Azathioprine is indicated as an adjunct for the prevention of rejection in kidney transplantation and for the management of active rheumatoid arthritis to reduce signs and symptoms.

According to IMS health, total sales of the tablet stood at $36 million (Rs 180 crore) for the year ended 3030 June 2008.

Read Business news in    Get Home Loan Counselling From HDFC - click here to know more.   HP 2133 Mini Note PC: Mini in size, Max in performance   Win a trip to the Malaysian Grand Prix - click here to know more   India's premier online business magazine   Free E-book on The Future of Business Intelligence Advt